Physician profile
Ashleigh Halderman
NPI 1689993180
$44,914.41
in general payments reported to CMS, 2019-2025
10 companies · $32K in 2025
The $32K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2021: $5,871 · 2022: $105 · 2023: $924 · 2024: $5,680 · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35K · Food and Beverage: $3,386 · Travel and Lodging: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $35,014.00 |
| Food and Beverage | $3,385.52 |
| Travel and Lodging | $233.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $27,807.53 | 2024-2025 | |
| Genzyme Corporation | $8,692.96 | 2025 | |
| Acclarent, INC | $6,249.43 | 2019-2023 | Trudi Nav Cable, Spine & Trauma 3d Navigation |
| 3-D Matrix, INC. | $989.48 | 2022-2025 | |
| Integra Lifesciences Corporation | $483.52 | 2024 | Trudi Probe, Inspira Air, Acclarent Aera |
| Medtronic, INC. | $259.59 | 2024-2025 | Propel, Pteye Parathyroid Detection System |
| Glaxosmithkline, LLC. | $183.93 | 2025 | Nucala |
| Olympus America INC. | $119.22 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $98.96 | 2024 | Dupixent |
| Stryker Corporation | $29.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashleigh Halderman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.